MTD
Price
$1309.12
Change
-$36.15 (-2.69%)
Updated
Oct 7 closing price
Capitalization
26.97B
29 days until earnings call
TMO
Price
$539.33
Change
-$4.62 (-0.85%)
Updated
Oct 7, 04:59 PM (EDT)
Capitalization
203.6B
14 days until earnings call
Interact to see
Advertisement

MTD vs TMO

Header iconMTD vs TMO Comparison
Open Charts MTD vs TMOBanner chart's image
Mettler-Toledo International
Price$1309.12
Change-$36.15 (-2.69%)
Volume$154.83K
Capitalization26.97B
Thermo Fisher Scientific
Price$539.33
Change-$4.62 (-0.85%)
Volume$11.53K
Capitalization203.6B
MTD vs TMO Comparison Chart in %
MTD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TMO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MTD vs. TMO commentary
Oct 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MTD is a StrongBuy and TMO is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 08, 2025
Stock price -- (MTD: $1309.12 vs. TMO: $539.17)
Brand notoriety: MTD and TMO are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: MTD: 111% vs. TMO: 87%
Market capitalization -- MTD: $26.97B vs. TMO: $203.6B
MTD [@Medical Specialties] is valued at $26.97B. TMO’s [@Medical Specialties] market capitalization is $203.6B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $11.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MTD’s FA Score shows that 1 FA rating(s) are green whileTMO’s FA Score has 0 green FA rating(s).

  • MTD’s FA Score: 1 green, 4 red.
  • TMO’s FA Score: 0 green, 5 red.
According to our system of comparison, MTD is a better buy in the long-term than TMO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MTD’s TA Score shows that 6 TA indicator(s) are bullish while TMO’s TA Score has 6 bullish TA indicator(s).

  • MTD’s TA Score: 6 bullish, 4 bearish.
  • TMO’s TA Score: 6 bullish, 5 bearish.
According to our system of comparison, MTD is a better buy in the short-term than TMO.

Price Growth

MTD (@Medical Specialties) experienced а +6.64% price change this week, while TMO (@Medical Specialties) price change was +11.16% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +3.09%. For the same industry, the average monthly price growth was +6.59%, and the average quarterly price growth was +39.05%.

Reported Earning Dates

MTD is expected to report earnings on Nov 06, 2025.

TMO is expected to report earnings on Oct 22, 2025.

Industries' Descriptions

@Medical Specialties (+3.09% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TMO($204B) has a higher market cap than MTD($27B). MTD has higher P/E ratio than TMO: MTD (33.19) vs TMO (31.18). MTD YTD gains are higher at: 6.982 vs. TMO (3.929). TMO has higher annual earnings (EBITDA): 11.3B vs. MTD (1.22B). TMO has more cash in the bank: 1.12B vs. MTD (61.8M). MTD has less debt than TMO: MTD (2.18B) vs TMO (35.2B). TMO has higher revenues than MTD: TMO (43.2B) vs MTD (3.87B).
MTDTMOMTD / TMO
Capitalization27B204B13%
EBITDA1.22B11.3B11%
Gain YTD6.9823.929178%
P/E Ratio33.1931.18106%
Revenue3.87B43.2B9%
Total Cash61.8M1.12B6%
Total Debt2.18B35.2B6%
FUNDAMENTALS RATINGS
MTD vs TMO: Fundamental Ratings
MTD
TMO
OUTLOOK RATING
1..100
6560
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
65
Fair valued
PROFIT vs RISK RATING
1..100
6766
SMR RATING
1..100
358
PRICE GROWTH RATING
1..100
5045
P/E GROWTH RATING
1..100
6363
SEASONALITY SCORE
1..100
7550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TMO's Valuation (65) in the Medical Specialties industry is somewhat better than the same rating for MTD (100). This means that TMO’s stock grew somewhat faster than MTD’s over the last 12 months.

TMO's Profit vs Risk Rating (66) in the Medical Specialties industry is in the same range as MTD (67). This means that TMO’s stock grew similarly to MTD’s over the last 12 months.

MTD's SMR Rating (3) in the Medical Specialties industry is somewhat better than the same rating for TMO (58). This means that MTD’s stock grew somewhat faster than TMO’s over the last 12 months.

TMO's Price Growth Rating (45) in the Medical Specialties industry is in the same range as MTD (50). This means that TMO’s stock grew similarly to MTD’s over the last 12 months.

TMO's P/E Growth Rating (63) in the Medical Specialties industry is in the same range as MTD (63). This means that TMO’s stock grew similarly to MTD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MTDTMO
RSI
ODDS (%)
Bullish Trend 1 day ago
65%
Bearish Trend 2 days ago
56%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
67%
Bearish Trend 2 days ago
57%
Momentum
ODDS (%)
Bullish Trend 1 day ago
69%
Bullish Trend 2 days ago
69%
MACD
ODDS (%)
Bullish Trend 1 day ago
55%
Bullish Trend 2 days ago
65%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
63%
Bullish Trend 2 days ago
61%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
60%
Bullish Trend 2 days ago
59%
Advances
ODDS (%)
Bullish Trend 2 days ago
62%
Bullish Trend 2 days ago
60%
Declines
ODDS (%)
Bearish Trend 9 days ago
62%
Bearish Trend 13 days ago
63%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
65%
Bearish Trend 2 days ago
61%
Aroon
ODDS (%)
Bearish Trend 1 day ago
62%
Bearish Trend 2 days ago
56%
View a ticker or compare two or three
Interact to see
Advertisement
MTD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TMO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
VSDM76.460.02
+0.03%
Vanguard Short Duration Tax-Exm Bd ETF
ZTRE51.19N/A
N/A
F/M 3-Yr Invmt Grd Corp Bd ETF
PAPR38.39-0.06
-0.15%
Innovator U.S. Equity PowerBffrETF™-Apr
XLC116.06-0.45
-0.39%
The Comm Svcs Sel Sect SPDR® ETF
PCGG12.45-0.09
-0.76%
Polen Capital Global Growth ETF

TMO and

Correlation & Price change

A.I.dvisor indicates that over the last year, TMO has been closely correlated with DHR. These tickers have moved in lockstep 80% of the time. This A.I.-generated data suggests there is a high statistical probability that if TMO jumps, then DHR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TMO
1D Price
Change %
TMO100%
-0.88%
DHR - TMO
80%
Closely correlated
-1.39%
A - TMO
80%
Closely correlated
-2.15%
MTD - TMO
76%
Closely correlated
-2.69%
RVTY - TMO
76%
Closely correlated
-2.35%
BRKR - TMO
67%
Closely correlated
-5.21%
More